1. T Helper and t regulatory cells modulation in head and neck squamous cell carcinoma
   Daniele Maggioni et al, 2017, OncoImmunology CrossRef
2. Local Immune Responsiveness of Mice Bearing Premalignant Oral Lesions to PD-1 Antibody Treatment
   Corinne Levingston et al, 2017, Cancers CrossRef
3. A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma
   Wei Sun et al, 2017, Br J Cancer CrossRef
4. IL-35 expression is increased in laryngeal squamous cell carcinoma and in the peripheral blood of patients
   Wei Wu et al, 2017 CrossRef
5. Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer
   Jian-Feng Liu et al, 2018, J Exp Clin Cancer Res CrossRef
6. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis
   Yi-hui Wen et al, 2018, Cancer Immunol Immunother CrossRef
7. Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma
   Imelda Seminerio et al, 2019, Cancers CrossRef
8. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination
   Fan-Qin Wei et al, 2016, J Exp Clin Cancer Res CrossRef
9. Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer
   M. Rita I. Young et al, 2016, Int. J. Cancer CrossRef
10. Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer
    Sumita Trivedi et al, 2016, Current Opinion in Otolaryngology & Head and Neck Surgery CrossRef
11. LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4+ regulatory T cell subpopulations mediated by 3G11 and CD127
    Fang Zhou et al, 2017, Immunol Res CrossRef
12. Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.
    Corinne A Levingston et al, 2017, Int J Cancer CrossRef
13. HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation
    Marcell Costa de Medeiros et al, 2017, Oncotarget CrossRef
14. Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma
    Wei Sun et al, 2016, Oncotarget CrossRef
15. Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
    Panagiota Economopoulou et al, 2020, Cancers CrossRef
16. Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis
    Juan P. Rodrigo et al, 2021, Biomedicines CrossRef
17. IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer
    Yi Zhao et al, 2021, Front. Oncol. CrossRef
18. Treg: A Promising Immunotherapeutic Target in Oral Diseases
    Yujing Zhang et al, 2021, Front. Immunol. CrossRef
19. Regulatory and effector T cell subsets in tumor-draining lymph nodes of patients with squamous cell carcinoma of head and neck
    Marzieh Norouzian et al, 2022, BMC Immunol CrossRef
20. Prognostic Impact of Tumor Immune Microenvironment and Its Predictive Role in Salivary Gland Cancer
    Maria Vittoria Veneroni et al, 2023, Head and Neck Pathol CrossRef
21. Exosomal PD-L1 derived from head and neck squamous cell carcinoma promotes immune evasion by activating the positive feedback loop of activated regulatory T cell-M2 macrophage
    Fanqin Wei et al, 2023, Oral Oncology CrossRef
22. Th2 Cells Are Associated with Tumor Recurrence Following Radiation
    Mohamed K. Abdelhakiem et al, 2024, Cancers CrossRef
23. Amphiregulin promotes activated regulatory T cell-suppressive function via the AREG/EGFR pathway in laryngeal squamous cell carcinoma
    Hang Li et al, 2024, Head Face Med CrossRef
24. Revealing the causal role of immune cells in malignant neoplasms of the head and neck: insights from Mendelian randomization
    En Zhou et al, 2024, Front. Oncol. CrossRef